Toggle light / dark theme

Waking up From the Dream of Longevity

In the course of the last century, science fiction has been a harbinger of things to come. From the automatic sliding doors of Star Trek to visual communication, cyberspace, and even the moon landing, many of our present technological achievements were dreamed up in the futuristic visions of science fiction authors of the 1960s and 70s. Indeed, the fantastical world of science fiction, while not intended to be prophetic, has ended up acting as a blueprint for our modern world.

We have learned from science fiction not only the possibilities of technology, however, but also its irreconcilable dangers. Readers of the genre will recognize the many stories warning us of the hazards of space travel, mind enhancement, and artificial intelligence. These fictional accounts cautioned that if we were not careful, our freedom to transform the world around us would transmogrify into a self-enforced slavery.

Nonetheless, while many of us remembered that these were just stories, intended as speculations about a possible future—in other words, they were fiction before science—through them, we became used to the idea that any advanced technology was inherently dangerous and its use always suspect. Moreover, it became a commonplace idea that technologies whose aim was to change or transform the human being—whether genetic, biological or reconstructive—would lead to a future worthy of Mary Shelley’s Frankenstein.

Google’s new Bristlecone processor brings it one step closer to quantum supremacy

Every major tech company is looking at quantum computers as the next big breakthrough in computing. Teams at Google, Microsoft, Intel, IBM and various startups and academic labs are racing to become the first to achieve quantum supremacy — that is, the point where a quantum computer can run certain algorithms faster than a classical computer ever could. Today, Google said that it believes that Bristlecone, its latest quantum processor, will put it on a path to reach quantum supremacy in the future.

The purpose of Bristlecone, Google says, it to provide its researchers with a testbed “for research into system error rates and scalability of our qubit technology, as well as applications in quantum simulation, optimization, and machine learning.

This AI has officially been granted residence

Tokyo, Japan may have just become the first city to officially grant residence to an artificial intelligence (AI). The intelligence’s name is Shibuya Mirai and exists only as a chatbot on the popular Line messaging app. Mirai, which translates to ‘future’ from Japanese, joins Hanson Robotic’s “Sophia” as pioneering AI gaining statuses previously reserved for living, biological entities. The Kingdom of Saudi Arabia granted Sophia citizenship last month.

The Shibuya Ward of Tokyo released a statement through Microsoft saying, “His hobbies are taking pictures and observing people. And he loves talking with people… Please talk to him about anything.” The goal of Mirai is said to be to familiarize some of the 224,000 citizens of the district with the local government and give them an avenue to share opinions with officials.

Mirai is programmed to be a seven-year-old boy and can have text conversations with users and even “make light-hearted alterations to selfies he is sent,” according to Agence France Presse.

Canadian astronaut David Saint-Jacques visits Montreal robotics competition

“To have the opportunity to talk to someone like that and to show what we did, it feels great,” said participant Ruby Novoa Forcier, 18.

Saint-Jacques’ visit was part of the Robotics FIRST (Favoriser l’Inspiration et la Reconnaissance des Sciences et de la Technologie) Quebec competition.

Around 5,000 students from different schools across Quebec, the United States and Europe got the chance to compete at the event.

China’s Google Equivalent Can Clone Voices After Seconds of Listening

Baidu’s AI research team has developed a nueral network that can mimic a voice with less than a minute long sample. The software can also change the voice into other genders and accents.

The Google of China, Baidu, has just released a white paper showing its latest development in artificial intelligence (AI): a program that can clone voices after analyzing even a seconds-long clip, using a neural network. Not only can the software mimic an input voice, but it can also change it to reflect another gender or even a different accent.

Can you trust a diagnosis made with the help of Artificial Intelligence?

The only difference is that in the case of the new technology Qure.ai is using, the artificial neuro network will be exposed to millions of cases instead of thousands. But can one trust a diagnosis made with the help of machines or AI? Human beings would typically trust another human being over a machine. But Warrier says that that is part and parcel of the diagnosis – human or artificial. Eighty-million chest X-rays happen in India every year, with radiology error rates for chest X-rays at 20–23 per cent. In fact, 19 per cent of lung nodules are missed! So even now if one goes to a trained radiologist, there are chances he can read or make a mistake in the diagnosis. But since the software runs through “millions” of scans instead of thousands as a human might, chances of an error are, in fact, lower. So chances of an error are, if anything, minimised. Secondly, as of now, Qure.ai is not producing a final report but developing a report that is ready for further analysis by a radiologist. “At locations across the country where radiologists are not available, this report can be the one that is physically available. It could go wrong but something is better than nothing,” argues Warrier. In cases where physicians disagree – often happens in cases like interstitial lung disease — the report produced through AI is “consistent and reproducible” and can be relied upon to arrive at a final conclusion. In India, Qure.ai has no competitors, but globally Zebra Medical Vision is the nearest competitor. The software has been adopted and deployed in five centres in Mumbai, Delhi, and Bengaluru. The company is also working with public health programmes in some countries. TB Reach has used it for processing TB cases (chest X-rays) from Nepal and Cameroon. Its solutions are being marketed in North America through its partners EnvoyAI (TeraRecon). According to Warrier, the global sales team of their parent company, Fractal Analytics, is helping them to reach out to health care providers and possible customers in the US and Europe. It may be early days yet, but if the technology and product prove as good as they claim, the benefits for patients will be felt for a long time to come.

/* */